Determined to head off a swine flu pandemic that is once again inspiring widespread fear, the European Medicines Agency has cleared a fast track for the development of a new vaccine, doing away with the need for large-scale human trials. Following a development format originally laid out in the event bird flu started to spread in humans, vaccine makers will be able to start providing the first doses of their new vaccines as early as next month. Report